
    
      PROTOCOL OUTLINE: Patients are stratified according to age at onset of symptoms (0-2 months
      vs 2-6 months vs greater than 6 months).

      Patients receive oral NTBC twice a day. Treatment continues in the absence of unacceptable
      toxicity.

      Patients are followed once a month for 6 months, then every 3 months thereafter.

      Completion date provided represents the completion date of the grant per OOPD records
    
  